Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
PaperCitations, authors & open-access status
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 182 citations, 2021 year and bronze oa status.
182
Citations
2021
Year
bronze
OA Status